Dr. Ramnath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Center Dr
B1 Floor Cancer Recp C
Ann Arbor, MI 48109Phone+1 734-647-8902Fax+1 734-936-9015- Is this information wrong?
Summary
- Dr. Nithya Ramnath is an oncologist in Ann Arbor, MI and is affiliated with multiple hospitals in the area, including University of Michigan Medical Center, Michigan Medicine, and Veterans Affairs Ann Arbor Healthcare System. She received her medical degree from Jawaharlal Institute of Postgraduate Medical Education and Research and has been in practice 28 years. She specializes in hematologic oncology and is experienced in thoracic oncology and general medical oncology.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1994 - 1996
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1992 - 1994
Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 1989
Certifications & Licensure
MI State Medical License 1994 - 2024
NY State Medical License 1999 - 2008
TX State Medical License 1996 - 2000- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors Start of enrollment: 1999 Mar 01
- Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors Start of enrollment: 2001 Aug 01
- BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 2002 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer.Chandan Bhambhani, Qing Kang, Daniel H Hovelson, Erin Sandford, Mary Olesnavich, Sarah M Dermody, Jenny Wolfgang, Kirsten L Tuck, Collin Brummel, Apurva D Bhangale, Ku...> ;JCI Insight. 2024 Feb 8
- Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer.Achreja, A., Nagrath, D., Reddy, R., Lagisetty, K., Lin, J., Chang, A., Ramnath, N., Dickson, R., Weinberg, F.> ;JTCVS Open. 2024 Feb 1
- Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy.Purcell, E., Niu, Z., Owen, S., Grzesik, M., Radomski, A., Kaehr, A., Onukwugha, N., Winkler, H., Nagrath, S., Ramnath, N., Lawrence, T., Jolly, S.> ;Cell Reports. 2024 Feb 27
- Join now to see all
Press Mentions
Vitamin D Linked to Lung Cancer Survival, Study SuggestsMarch 1st, 2011
Scientists 'Farm' Natural Killer Cells in Novel Cancer Fighting ApproachJanuary 29th, 2021
Grant Support
- The Role Of Vitamin D Metabolism In Non-Small Cell Lung CancerVeterans Affairs2011
- A Phase I/II Clinical Trial Of Intravenous (I.V.) Calcitriol With Fixed Doses OfNational Cancer Institute2008–2009
- A Phase I/II Clinical Trial Of Intravenous (I.V.) Calcitriol With Fixed Doses OfNational Cancer Institute2008
Professional Memberships
- Member
Hospital Affiliations
University of Michigan Medical CenterAnn Arbor, Michigan
Veterans Affairs Ann Arbor Healthcare SystemAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
